Clinical Chemistry and Laboratory Medicine (CCLM),
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 18, 2025
Abstract
Objectives
Accurate
medical
laboratory
reports
are
essential
for
delivering
high-quality
healthcare.
Recently,
advanced
artificial
intelligence
models,
such
as
those
in
the
ChatGPT
series,
have
shown
considerable
promise
this
domain.
This
study
assessed
performance
of
specific
GPT
models-namely,
4o,
o1,
and
o1
mini-in
identifying
errors
within
providing
treatment
recommendations.
Methods
In
retrospective
study,
86
Nucleic
acid
test
report
seven
upper
respiratory
tract
pathogens
were
compiled.
There
285
from
four
common
error
categories
intentionally
randomly
introduced
into
generated
incorrected
reports.
models
tasked
with
detecting
these
errors,
using
three
senior
scientists
(SMLS)
interns
(MLI)
control
groups.
Additionally,
generating
accurate
reliable
recommendations
following
positive
outcomes
based
on
corrected
χ2
tests,
Kruskal-Wallis
Wilcoxon
tests
used
statistical
analysis
where
appropriate.
Results
comparison
SMLS
or
MLI,
accurately
detected
types,
average
detection
rates
88.9
%(omission),
91.6
%
(time
sequence),
91.7
(the
same
individual
acted
both
inspector
reviewer).
However,
rate
result
input
format
by
was
only
51.9
%,
indicating
a
relatively
poor
aspect.
exhibited
substantial
to
almost
perfect
agreement
total
(kappa
[min,
max]:
0.778,
0.837).
between
MLI
moderately
lower
0.632,
0.696).
When
it
comes
reading
all
reports,
showed
obviously
reduced
time
compared
(all
p<0.001).
Notably,
our
also
found
GPT-o1
mini
model
had
better
consistency
identification
than
model,
which
that
GPT-4o
model.
The
pairwise
comparisons
model’s
outputs
across
repeated
runs
0.912,
0.996).
GPT-o1(all
significantly
outperformed
p<0.0001).
Conclusions
capability
some
accuracy
reliability
competent,
especially,
potentially
reducing
work
hours
enhancing
clinical
decision-making.
Humanities and Social Sciences Communications,
Journal Year:
2024,
Volume and Issue:
11(1)
Published: March 15, 2024
Abstract
The
purpose
of
this
research
is
to
identify
and
evaluate
the
technical,
ethical
regulatory
challenges
related
use
Artificial
Intelligence
(AI)
in
healthcare.
potential
applications
AI
healthcare
seem
limitless
vary
their
nature
scope,
ranging
from
privacy,
research,
informed
consent,
patient
autonomy,
accountability,
health
equity,
fairness,
AI-based
diagnostic
algorithms
care
management
through
automation
for
specific
manual
activities
reduce
paperwork
human
error.
main
faced
by
states
regulating
were
identified,
especially
legal
voids
complexities
adequate
regulation
better
transparency.
A
few
recommendations
made
protect
data,
mitigate
risks
regulate
more
efficiently
international
cooperation
adoption
harmonized
standards
under
World
Health
Organization
(WHO)
line
with
its
constitutional
mandate
digital
public
health.
European
Union
(EU)
law
can
serve
as
a
model
guidance
WHO
reform
International
Regulations
(IHR).
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(5), P. 1605 - 1605
Published: Feb. 27, 2025
Background/Objectives:
Artificial
intelligence
(AI)
is
transforming
healthcare,
enabling
advances
in
diagnostics,
treatment
optimization,
and
patient
care.
Yet,
its
integration
raises
ethical,
regulatory,
societal
challenges.
Key
concerns
include
data
privacy
risks,
algorithmic
bias,
regulatory
gaps
that
struggle
to
keep
pace
with
AI
advancements.
This
study
aims
synthesize
a
multidisciplinary
framework
for
trustworthy
focusing
on
transparency,
accountability,
fairness,
sustainability,
global
collaboration.
It
moves
beyond
high-level
ethical
discussions
provide
actionable
strategies
implementing
clinical
contexts.
Methods:
A
structured
literature
review
was
conducted
using
PubMed,
Scopus,
Web
of
Science.
Studies
were
selected
based
relevance
ethics,
governance,
policy
prioritizing
peer-reviewed
articles,
analyses,
case
studies,
guidelines
from
authoritative
sources
published
within
the
last
decade.
The
conceptual
approach
integrates
perspectives
clinicians,
ethicists,
policymakers,
technologists,
offering
holistic
“ecosystem”
view
AI.
No
trials
or
patient-level
interventions
conducted.
Results:
analysis
identifies
key
current
governance
introduces
Regulatory
Genome—an
adaptive
oversight
aligned
trends
Sustainable
Development
Goals.
quantifiable
trustworthiness
metrics,
comparative
categories
applications,
bias
mitigation
strategies.
Additionally,
it
presents
interdisciplinary
recommendations
aligning
deployment
environmental
sustainability
goals.
emphasizes
measurable
standards,
multi-stakeholder
engagement
strategies,
partnerships
ensure
future
innovations
meet
practical
healthcare
needs.
Conclusions:
Trustworthy
requires
more
than
technical
advancements—it
demands
robust
safeguards,
proactive
regulation,
continuous
By
adopting
recommended
roadmap,
stakeholders
can
foster
responsible
innovation,
improve
outcomes,
maintain
public
trust
AI-driven
healthcare.
Health care science,
Journal Year:
2024,
Volume and Issue:
3(5), P. 329 - 349
Published: Oct. 1, 2024
Abstract
The
increasing
integration
of
new
technologies
is
driving
a
fundamental
revolution
in
the
healthcare
sector.
Developments
artificial
intelligence
(AI),
machine
learning,
and
big
data
analytics
have
completely
transformed
diagnosis,
treatment,
care
patients.
AI‐powered
solutions
are
enhancing
efficiency
accuracy
delivery
by
demonstrating
exceptional
skills
personalized
medicine,
early
disease
detection,
predictive
analytics.
Furthermore,
telemedicine
remote
patient
monitoring
systems
overcome
geographical
constraints,
offering
easy
accessible
services,
particularly
underserved
areas.
Wearable
technology,
Internet
Medical
Things,
sensor
empowered
individuals
to
take
an
active
role
tracking
managing
their
health.
These
devices
facilitate
real‐time
collection,
enabling
preventive
care.
Additionally,
development
3D
printing
technology
has
revolutionized
medical
field
production
customized
prosthetics,
implants,
anatomical
models,
significantly
impacting
surgical
planning
treatment
strategies.
Accepting
these
advancements
holds
potential
create
more
patient‐centered,
efficient
system
that
emphasizes
individualized
care,
better
overall
health
outcomes.
This
review's
novelty
lies
exploring
how
radically
transforming
industry,
paving
way
for
effective
all.
It
highlights
capacity
modern
revolutionize
addressing
long‐standing
challenges
improving
Although
approval
use
digital
advanced
analysis
face
scientific
regulatory
obstacles,
they
translational
research.
as
continue
evolve,
poised
alter
environment,
sustainable,
efficient,
ecosystem
future
generations.
Innovation
across
multiple
fronts
will
shape
revolutionizing
provision
healthcare,
outcomes,
equipping
both
patients
professionals
with
tools
make
decisions
receive
treatment.
As
develop
become
integrated
into
standard
practices,
probably
be
accessible,
effective,
than
ever
before.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(1), P. e0315270 - e0315270
Published: Jan. 3, 2025
The
latest
global
progress
report
highlights
numerous
challenges
in
achieving
justice
goals,
with
bias
artificial
intelligence
(AI)
emerging
as
a
significant
yet
underexplored
issue.
This
paper
investigates
the
role
of
AI
addressing
within
judicial
system
to
promote
equitable
social
justice.
Analyzing
weekly
data
from
January
1,
2019,
December
31,
2023,
through
wavelet
quantile
correlation,
this
study
examines
short,
medium,
and
long-term
impacts
integrating
AI,
media,
international
legal
influence
(ILI),
financial
institutions
(IFI)
crucial
factors
Sustainable
Development
Goal
16
(SDG-16),
which
focuses
on
findings
indicate
that
ILI,
IFI
can
help
reduce
medium
long
term,
although
their
effects
appear
mixed
less
short
term.
Our
research
proposes
comprehensive
policy
framework
addresses
complexities
implementing
these
technologies
system.
We
conclude
successfully
requires
supportive
environment
embraces
technological
innovation,
backing,
robust
regulation
prevent
potential
disruptions
could
reinforce
inequalities,
perpetuate
structural
injustices,
exacerbate
human
rights
issues,
ultimately
leading
more
biased
outcomes
Dermatological Reviews,
Journal Year:
2025,
Volume and Issue:
6(1)
Published: Jan. 17, 2025
ABSTRACT
Background
Artificial
intelligence
(AI)
is
transforming
dermatopathology
by
enhancing
diagnostic
accuracy,
efficiency,
and
precision
medicine.
Despite
its
promise,
challenges
such
as
dataset
biases,
underrepresentation
of
diverse
populations,
limited
transparency
hinder
widespread
adoption.
Addressing
these
gaps
can
set
a
new
standard
for
equitable
patient‐centered
care.
To
evaluate
how
AI
mitigates
improves
interpretability,
promotes
inclusivity
in
while
highlighting
novel
technologies
like
multimodal
models
explainable
(XAI).
Results
AI‐driven
tools
demonstrate
significant
improvements
precision,
particularly
through
that
integrate
histological,
genetic,
clinical
data.
Inclusive
frameworks,
the
Monk
scale,
advanced
segmentation
methods
effectively
address
biases.
However,
“black
box”
nature
AI,
ethical
concerns
about
data
privacy,
access
to
low‐resource
settings
remain.
Conclusion
offers
transformative
potential
dermatopathology,
enabling
equitable,
innovative
diagnostics.
Overcoming
persistent
will
require
collaboration
among
dermatopathologists,
developers,
policymakers.
By
prioritizing
inclusivity,
transparency,
interdisciplinary
efforts,
redefine
global
standards
foster
IP Indian Journal of Clinical and Experimental Dermatology,
Journal Year:
2025,
Volume and Issue:
11(1), P. 1 - 9
Published: Feb. 8, 2025
Medicine
is
entering
a
transformative
era
with
disruptive
technologies
such
as
virtual
reality,
genomic
prediction,
data
analytics,
personalized
medicine,
stem
cell
therapy,
3-D
printing,
and
nanorobotics.
Dermatology
significantly
impacted
by
these
advancements,
particularly
through
artificial
intelligence
(AI).
AI,
defined
devices
performing
functions
typically
requiring
human
intelligence,
plays
an
increasingly
prominent
role
in
healthcare.
John
McCarthy
coined
the
term
AI
1956.
In
dermatology,
aids
diagnosis,
treatment
planning,
understanding
diseases
across
communities.
Machine
learning
deep
learning,
subsets
of
require
extensive
datasets
robust
analysis
to
improve
accuracy
performance.
AI's
integration
into
dermatology
revolutionizing
field
enabling
precision,
reducing
errors,
minimizing
staffing
needs.
tools
support
dermatologists
diagnosing
treating
various
conditions,
from
psoriasis
acne
dermatitis
ulcers.
Convolutional
neural
networks
(CNNs)
enhance
classification
skin
lesions,
while
predictive
models
optimize
strategies
based
on
patient
data.
extends
oncology,
where
it
improves
cancer
detection
image
histopathological
assessment.
Despite
its
potential,
faces
challenges
quality,
representativeness,
algorithm
transparency,
ethical
considerations.
Addressing
biases,
standardizing
imaging
protocols,
enhancing
human-machine
collaboration
are
crucial
for
maximizing
benefits.
holds
immense
promise
offering
innovative
solutions
care
diagnostic
accuracy.
The
future
includes
advancements
vision-language
models,
federated
precision
medicine
approaches.
Overcoming
related
privacy,
regulatory
standards,
model
evaluation
essential
successful
clinical
practice.
Collaborative
efforts
among
stakeholders
vital
drive
progress
realize
full
potential
ultimately
improving
outcomes
globally.
Advances in computational intelligence and robotics book series,
Journal Year:
2024,
Volume and Issue:
unknown, P. 272 - 287
Published: April 26, 2024
The
healthcare
industry
is
currently
experiencing
a
groundbreakingly
revolution
as
cloud
robotics
and
artificial
intelligence
(AI)
come
together.
This
research
examines
the
synergistic
relationship
between
these
two
advanced
technologies
their
significant
influence
on
improving
patient
care.
Through
utilisation
of
cloud-based
computing
power
capabilities
intelligent
robotics,
systems
can
attain
unparalleled
levels
efficiency,
accessibility,
personalisation.
Integrating
AI
algorithms
with
robotic
enables
enhanced
diagnosis,
treatment
planning,
real-time
monitoring,
ultimately
resulting
in
outcomes.
chapter
present
condition
technologies,
explores
instances
where
they
have
been
effectively
put
into
practice,
highlights
possible
obstacles
ethical
concerns.
In
this
era
transformation,
it
essential
to
recognise
collaborative
designing
future
patient-centred,
data-driven
systems.